Clinical effectiveness of nirmatrelvir plus ritonavir for patients with COVID-19 and preexisting psychiatric disorders-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical effectiveness of nirmatrelvir plus ritonavir for patients with COVID-19 and preexisting psychiatric disorders

Published:2024-05-11 Issue: Volume: Page:1-9
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Liu Ting-Hui¹,Wu Jheng-Yan²^ORCID,Huang Po-Yu³,Hsu Wan-Hsuan¹^ORCID,Chuang Min-Hsiang³,Tsai Ya-Wen⁴,Lai Chih-Cheng⁵⁶^ORCID,Huang Charles Lung-Cheng¹⁷

Affiliation:

1. Department of Psychiatry, Chi Mei Medical Center, Tainan, Taiwan

2. Department of Nutrition, Chi Mei Medical Center, Tainan, Taiwan

3. Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan

4. Center for Integrative Medicine, Chi Mei Medical Center, Tainan, Taiwan

5. Division of Hospital Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan

6. School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan

7. Department of Medicinal and Applied Chemistry, Kaohsiung Medical University, Kaohsiung, Taiwan

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2024.2351555

Reference38 articles.

1. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status

2. World Health Organization. [cited 2023 Jan 27]. Available from: https://covid19.who.int/

3. Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death

4. Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer

5. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3